Cited by 279Alzheimer's disease research and treatmentsPrion Diseases and Protein MisfoldingNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation

Open access

Eisele, Yvonne S., Bolmont, Tristan, Heikenwalder, Mathias, Langer, Franziska, Jacobson, Laura H., Yan, Zheng-Xin, Roth, Klaus, Aguzzi, Adriano, Staufenbiel, Matthias, Walker, Lary C., Jucker, Mathias·2009·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0903200106PMC PMC2722323

Open this paper in CoChat — free account

Abstract

Despite the importance of the aberrant polymerization of Aβ in the early pathogenic cascade of Alzheimer's disease, little is known about the induction of Aβ aggregation in vivo. Here we show that induction of cerebral β-amyloidosis can be achieved in many different brain areas of APP23 transgenic mice through the injection of dilute Aβ-containing brain extracts. Once the amyloidogenic process has been exogenously induced, the nature of the induced Aβ-deposition is determined by the brain region of the host. Because these observations are reminiscent of a prion-like mechanism, we then investigated whether cerebral β-amyloidosis also can be induced by peripheral and systemic inoculations or by the intracerebral implantation of stainless steel wires previously coated with minute amounts of Aβ-containing brain extract. Results reveal that oral, intravenous, intraocular, and intranasal inoculations yielded no detectable induction of cerebral β-amyloidosis in APP23 transgenic mice. In contrast, transmission of cerebral β-amyloidosis through the Aβ-contaminated steel wires was demonstrated. Notably, plasma sterilization, but not boiling of the wires before implantation, prevented the induction of β-amyloidosis. Our results suggest that minute amounts of Aβ-containing brain material in direct contact with the CNS can induce cerebral β-amyloidosis, but that systemic cellular mechanisms of prion uptake and transport to the CNS may not apply to Aβ.

Integrity signals

Registry

Crossref · 10.1073/pnas.0903200106

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Self-citation
Folding proteins in fatal ways
Selkoe, D. J. (2003) · Nature · doi:10.1038/nature02264 · Cited by 1,432
A General Model of Prion Strains and Their Pathogenicity
Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,075
Synthetic Mammalian Prions
Legname, G., Baskakov, I. V., Nguyen, H.-O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2004) · Science · doi:10.1126/science.1100195 · Cited by 1,022
Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host
Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P., Jaton, A. L., et al. (2006) · Science · doi:10.1126/science.1131864 · Cited by 971
Self-citation
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 829
Normal host prion protein necessary for scrapie-induced neurotoxicity
Brandner, S., Isenmann, S., Raeber, A. J., Fischer, M., Sailer, A. W., Kobayashi, Y., Marino, S., Weissmann, C., & Aguzzi, A. (1996) · Nature · doi:10.1038/379339a0 · Cited by 813
Self-citation
Prion biology and diseases.
Prusiner, S. B. (1991) · PubMed · Cited by 641
DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERY
Bernoulli, C., Siegfried, J., Baumgartner, G., Regli, F., Rabinowicz, T., Gajdusek, D. C., & Gibbs, C. J. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91958-4 · Cited by 508
Neuron loss in APP transgenic mice
Calhoun, M. E., Wiederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., & Jucker, M. (1998) · Nature · doi:10.1038/27351 · Cited by 502
Self-citation

Flagged first, then by citations

Show all 44 references

Sorted by citations

Items 101–200 of 279

Crucial Role for Prion Protein Membrane Anchoring in the Neuroinvasion and Neural Spread of Prion Infection
Klingeborn, M., Race, B., Meade-White, K. D., Rosenke, R., Striebel, J. F., & Chesebro, B. W. (2010) · Journal of Virology · doi:10.1128/jvi.02167-10 · Cited by 59
Progression of Seed‐Induced A β Deposition within the Limbic Connectome
Ye, L., Hamaguchi, T., Fritschi, S. K., Eisele, Y. S., Obermüller, U., Jucker, M., & Walker, L. C. (2015) · Brain Pathology · doi:10.1111/bpa.12252 · Cited by 60
Self-citation
The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer’s disease
Lau, H. H. C., Ingelsson, M., & Watts, J. C. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02201-2 · Cited by 57
Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration
Gentile, F., Doneddu, P. E., Riva, N., Nobile‐Orazio, E., & Quattrini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207471 · Cited by 58
Nanofibrils of food‐grade proteins: Formation mechanism, delivery systems, and application evaluation
An, D., Ban, Q., Du, H., Wang, Q., Teng, F., Li, L., & Xiao, H. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13028 · Cited by 54
Amyloid Beta Inhibits Olfactory Bulb Activity and the Ability to Smell
Alvarado-Martínez, R., Salgado-Puga, K., & Peña‐Ortega, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075745 · Cited by 54
Conformational Transformation and Selection of Synthetic Prion Strains
Ghaemmaghami, S., Watts, J. C., Nguyen, H.-O. B., Hayashi, S., DeArmond, S. J., & Prusiner, S. B. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.07.021 · Cited by 53
An Efficient Procedure for Removal and Inactivation of Alpha-Synuclein Assemblies from Laboratory Materials
Bousset, L., Brundin, P., Böckmann, A., Meier, B., & Melki, R. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-150691 · Cited by 53
Prion Diseases
Tee, B. L., Longoria-Ibarrola, E. M., & Geschwind, M. D. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.07.005 · Cited by 58
Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease
Chiarini, A., Armato, U., Liu, D., & Dal Prà, I. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00134 · Cited by 51
How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer’s Disease and Other Neurodegenerative Disorders
Carlson, G. A., & Prusiner, S. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094861 · Cited by 51
Titration of biologically active amyloid–β seeds in a transgenic mouse model of Alzheimer's disease
Morales, R., Bravo-Alegria, J. B., Duran-Aniotz, C. A., & Soto, C. A. (2015) · Scientific Reports · doi:10.1038/srep09349 · Cited by 49
Intracerebral seeding of amyloid-β and tau pathology in mice: Factors underlying prion-like spreading and comparisons with α-synuclein
McAllister, B. B., Lacoursiere, S. G., Sutherland, R. J., & Mohajerani, M. H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.026 · Cited by 48
Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease
Rosen, R. F., Tomidokoro, Y., Farberg, A. S., Dooyema, J., Ciliax, B., Preuss, T. M., Neubert, T. A., Ghiso, J. A., LeVine, H., & Walker, L. C. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.019 · Cited by 46
Self-citation
Microglial VPS35 deficiency impairs Aβ phagocytosis and Aβ-induced disease-associated microglia, and enhances Aβ associated pathology
Ren, X., Yao, L., Wang, Y., Mei, L., & Xiong, W.-C. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02422-0 · Cited by 42
Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
Dhillon, J.-K. S., Trejo‐Lopez, J. A., Riffe, C. J., Levites, Y., Sacino, A. N., Borchelt, D., Yachnis, A. T., & Giasson, B. I. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0733-3 · Cited by 47
Expanding spectrum of prion diseases
Ayers, J. I., Paras, N. A., & Prusiner, S. B. (2020) · Emerging Topics in Life Sciences · doi:10.1042/etls20200037 · Cited by 45
Mechanism of aggregation and membrane interactions of mammalian prion protein
Thody, S. A., Mathew, M. K., & Udgaonkar, J. B. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.02.031 · Cited by 42
The cellular and pathologic prion protein
Gill, A. C., & Castle, A. R. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00002-7 · Cited by 45
Aβ Seeding as a Tool to Study Cerebral Amyloidosis and Associated Pathology
Friesen, M., & Meyer‐Luehmann, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00233 · Cited by 41
Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice
Kulikova, A. A., Cheglakov, I. B., Kukharsky, M. S., Ovchinnikov, R. K., Kozin, S. A., & Makarov, A. А. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9603-y · Cited by 41
From Soluble A β to Progressive A β Aggregation: Could Prion‐Like Templated Misfolding Play a Role?
Eisele, Y. S. (2013) · Brain Pathology · doi:10.1111/bpa.12049 · Cited by 43
Self-citation
Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease
Zhao, Y., Zhang, Y., Zhang, J., Zhang, X., & Yang, G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200114163636 · Cited by 40
The prion-like phenomenon in Alzheimer’s disease: Evidence of pathology transmission in humans
Gomez‐Gutierrez, R., & Morales, R. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009004 · Cited by 39
Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer’s Disease
Spilman, P. R., Corset, V., Gorostiza, O., Poksay, K. S., Galvan, V., Zhang, J., Rao, R., Peters-Libeu, C., Vincelette, J., McGeehan, A., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-151046 · Cited by 39
Age-dependent inverse correlations in CSF and plasma amyloid-β(1–42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice
Cho, S. M., Lee, S., Yang, S., Kim, H. Y., Lee, M. J., Kim, H. V., Kim, J., Baek, S., Yun, J., Kim, D., et al. (2016) · Scientific Reports · doi:10.1038/srep20185 · Cited by 39
Anti-amyloid Therapy of Alzheimer’s Disease: Current State and Prospects
Kozin, S. A., Barykin, E. P., Mitkevich, V. A., & Makarov, A. А. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918090079 · Cited by 39
Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain
Mazzitelli, S., Filipello, F., Rasile, M., Lauranzano, E., Cucuzza, C. S., Tamborini, M., Pozzi, D., Barajon, I., Toni Giorgino, A., Natalello, A., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0381-9 · Cited by 38
Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
Wısnıewskı, T., & Boutajangout, A. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0236-2 · Cited by 39
Lung endothelium, tau, and amyloids in health and disease
Balczon, R., Lin, M. T., Voth, S. B., Nelson, A. R., Schupp, J. C., Wagener, B. M., Pittet, J., & Stevens, T. (2023) · Physiological Reviews · doi:10.1152/physrev.00006.2023 · Cited by 40
Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease
Eleuteri, S., Giovanni, S. D., Rockenstein, E. M., Mante, M., Adame, A., Trejo, M., Wrasidlo, W., Wu, F., Fraering, P. C., Masliah, E., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.017 · Cited by 40
Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie, D. L., & Barria, M. A. (2021) · Biomolecules · doi:10.3390/biom11020207 · Cited by 41
Evidence for Prion-Like Mechanisms in Several Neurodegenerative Diseases: Potential Implications for Immunotherapy
Marciniuk, K., Taschuk, R., & Napper, S. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/473706 · Cited by 39
Convergent Replication of Mouse Synthetic Prion Strains
Ghaemmaghami, S., Colby, D. W., Nguyen, H.-O. B., Hayashi, S., Oehler, A., DeArmond, S. J., & Prusiner, S. B. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.038 · Cited by 36
Enhanced neuroinvasion by smaller, soluble prions
Bett, C. K., Lawrence, J., Kurt, T. D., Orru, C. D., Aguilar‐Calvo, P., Kincaid, A. E., Surewicz, W. K., Caughey, B. W., Wu, C., & Sigurdson, C. J. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0430-z · Cited by 36
Effect of aging and Alzheimer's disease-like pathology on brain monoamines in mice
von Linstow, C. U., Severino, M., Metaxas, A., Waider, J., Babcock, A. A., Lesch, K., Gramsbergen, J. B., & Finsen, B. R. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.04.008 · Cited by 35
Roles of zinc ions and structural polymorphism of β-amyloid in the development of Alzheimer’s disease
Kulikova, A. A., Makarov, A. А., & Kozin, S. A. (2015) · Molecular Biology · doi:10.1134/s0026893315020065 · Cited by 35
Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns
Asher, D. M., Belay, E. D., Bigio, E. H., Brandner, S., Brubaker, S. A., Caughey, B. W., Clark, B., Damon, I. K., Diamond, M. I., Freund, M. P., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa109 · Cited by 35
Self-citation
Amyloid-β containing isoaspartate 7 as potential biomarker and drug target in Alzheimer's disease
Kozin, S. A., Mitkevich, V. A., & Makarov, A. А. (2016) · Mendeleev Communications · doi:10.1016/j.mencom.2016.07.001 · Cited by 33
The Blood-Brain Barrier in Alzheimer’s Disease
Storck, S. E., Hartz, A. M. S., & Pietrzik, C. U. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_418 · Cited by 31
Prion-like Mechanisms in Alzheimer's Disease
Yin, R., Tan, L., Jiang, T., & Yu, J. (2014) · Current Alzheimer Research · doi:10.2174/156720501108140910121425 · Cited by 33
Trans-Synaptic Spread of Amyloid-βin Alzheimer’s Disease: Paths toβ-Amyloidosis
Pignataro, A., & Middei, S. (2017) · Neural Plasticity · doi:10.1155/2017/5281829 · Cited by 34
Bioassays and Inactivation of PrionsPreprint
Giles, K., Woerman, A. L., Berry, D. B., & Prusiner, S. B. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023499 · Cited by 33
Iatrogenic cerebral amyloid angiopathy: A multinational case series and individual patient data analysis of the literature
Pikija, S., Oblak, J. P., Frol, S., Malojčić, B., Gattringer, T., Rak‐Frattner, K., Staykov, D., Salmaggi, A., Milani, R., Magdič, J., et al. (2023) · International Journal of Stroke · doi:10.1177/17474930231203133 · Cited by 34
Insights into Mechanisms of Chronic Neurodegeneration
Diack, A. B., Alibhai, J. D., Barron, R. M., Bradford, B. M., Piccardo, P., & Manson, J. C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010082 · Cited by 31
Biomarkers of Alzheimer’s disease in severe obstructive sleep apnea–hypopnea syndrome in the Chinese population
Kong, W., Zheng, Y., Xu, W., Gu, H., & Wu, J. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05948-2 · Cited by 31
Transmission of cerebral amyloid pathology by peripheral administration of misfolded Aβ aggregates
Morales, R., Bravo-Alegria, J. B., Moreno‐González, I., Duran-Aniotz, C. A., Gamez, N., Edwards, G. A., & Soto, C. A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01150-w · Cited by 31
HSA targets multiple Aβ42 species and inhibits the seeding-mediated aggregation and cytotoxicity of Aβ42 aggregates
Wang, C., Cheng, F., Xu, L., & Jia, L. (2016) · RSC Advances · doi:10.1039/c6ra14590f · Cited by 32
Operational dissection of β‐amyloid cytopathic effects on cultured neurons
Callizot, N., Combes, M., Steinschneider, R., & Poindron, P. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23193 · Cited by 30
Synaptic Protein Alterations in Parkinson’s Disease
Pienaar, I. S., Burn, D. J., Morris, C. M., & Dexter, D. T. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8226-9 · Cited by 28
PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions
Barron, R. M., King, D., Jeffrey, M., McGovern, G., Agarwal, S., Gill, A. C., & Piccardo, P. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1594-5 · Cited by 30
Prion-Like Behavior of Amyloid-β
Kim, J., & Holtzman, D. M. (2010) · Science · doi:10.1126/science.1198314 · Cited by 27
Experimental modeling of Alzheimer's disease: Translational lessons from cross‐taxon analyses
Yenkoyan, K. B., Kotova, M. M., Apukhtin, K. V., Galstyan, D. S., Amstislavskaya, T. G., Strekalova, T. V., de Abreu, M. S., Chavushyan, V. A., Lim, L. W., Yang, L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70273 · Cited by 30
Remodeling Alzheimer-amyloidosis models by seeding
Ulm, B. S., Borchelt, D., & Moore, B. D. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00429-4 · Cited by 26
GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells
Speare, J. O., Offerdahl, D. K., Hasenkrug, A. M., Carmody, A., & Baron, G. S. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.392 · Cited by 27
Self-Propagative Replication of Aβ Oligomers Suggests Potential Transmissibility in Alzheimer Disease
Kumar, A., Pate, K. M., Moss, M. A., Dean, D. N., & Rangachari, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111492 · Cited by 26
Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism
Fernández‐Borges, N., Eraña, H., Elezgarai, S. R., Harrathi, C., Gayosso, M., & Castilla, J. (2013) · International Journal of Cell Biology · doi:10.1155/2013/583498 · Cited by 26
Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins
Eraña, H., Venegas, V., Charco, J. M., & Castilla, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.166 · Cited by 26
The calcium-sensing receptor: A novel Alzheimer's disease crucial target?
Armato, U., Bonafini, C., Chakravarthy, B., Pacchiana, R., Chiarini, A., Whitfield, J. F., & Prà, I. D. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.031 · Cited by 25
The role of monoamines in the development of Alzheimer's disease and neuroprotective effect of a proline rich polypeptide
Yenkoyan, K. B., Fereshetyan, K., Matinyan, S., Chavushyan, V. A., & Aghajanov, M. I. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.05.013 · Cited by 25
Next generation therapeutics for Alzheimer's disease
Bredesen, D. E., & John, V. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202307 · Cited by 25
Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates
Thomzig, A., Wagenführ, K., Daus, M. L., Joncic, M., Schulz‐Schaeffer, W., Thanheiser, M., Mielke, M. E. A., & Beekes, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0151-5 · Cited by 24
Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time
Muth, C., Schröck, K., Madore, C., Hartmann, K., Fanek, Z., Butovsky, O., Glatzel, M., & Krasemann, S. (2017) · Brain Pathology · doi:10.1111/bpa.12441 · Cited by 23
Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer’s disease
George, S., Rönnbäck, A., Gouras, G. K., Petit, G. H., Grueninger, F., Winblad, B., Graff, C., & Brundin, P. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-17 · Cited by 23
Harnessing prions as test agents for the development of broad-range disinfectants
Wagenführ, K., & Beekes, M. (2012) · Prion · doi:10.4161/pri.6.1.18556 · Cited by 23
The pertussis hypothesis: Bordetella pertussis colonization in the pathogenesis of Alzheimer’s disease
Rubin, K., & Glazer, S. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.09.017 · Cited by 22
Analysis of Amyloid Beta Aggregation Kinetics Using Sym‐Triazine β‐Sheet Inhibitors
Veloso, A. J., Hung, V. W. S., Cheng, X. R., & Kerman, K. (2012) · Electroanalysis · doi:10.1002/elan.201200216 · Cited by 22
Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-β
Nies, S. H., Takahashi, H., Herber, C. S., Huttner, A. J., Chase, A., & Strittmatter, S. M. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101159 · Cited by 25
Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer’s Disease
Kozin, S. A., Kechko, O. I., Adzhubei, A. A., Makarov, A. А., & Mitkevich, V. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010072 · Cited by 21
Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease
Barilar, J. O., Knezović, A., Perhoč, A. B., Homolak, J., Riederer, P. F., & Šalković‐Petrišić, M. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02152-8 · Cited by 22
Analysis of Amyloid-β Pathology Spread in Mouse Models Suggests Spread Is Driven by Spatial Proximity, Not Connectivity
Mezias, C., & Raj, A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00653 · Cited by 21
Induction et propagation de la pathologie par la protéine tau chez un modèle murin de la maladie d’Alzheimer
Clavaguera, F., Goedert, M., & Tolnay, M. (2010) · médecine/sciences · doi:10.1051/medsci/2010262121 · Cited by 22
Spontaneous intracerebral haemorrhage associated with early-onset cerebral amyloid angiopathy and Alzheimer’s disease neuropathological changes five decades after cadaveric dura mater graft
Milani, R., Mazzeo, L. A., Vismara, D., Salemi, I., Dainese, E., Maderna, E., Pellencin, E., Catania, M., Campanella, N., Fede, G. D., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01528-7 · Cited by 20
Unaltered prion protein expression in Alzheimer disease patients
Saijo, E., Scheff, S. W., & Telling, G. C. (2011) · Prion · doi:10.4161/pri.5.2.16355 · Cited by 19
Prion-like transmission of pathogenic protein aggregates in genetic models of neurodegenerative disease
Pearce, M. M. P. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.03.011 · Cited by 19
Transport of cargo from periphery to brain by circulating monocytes
Cintron, A. F., Dalal, N. V., Dooyema, J. M., Betarbet, R. S., & Walker, L. C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.047 · Cited by 19
Self-citation
The Convergence of Alzheimer’s Disease Pathogenesis Concepts
Kozin, S. A., & Makarov, A. А. (2019) · Molecular Biology · doi:10.1134/s0026893319060104 · Cited by 17
Follow-up study of a patient with early onset cerebral amyloid angiopathy following childhood cadaveric dural graft
Yoshiki, K., Hirose, G., Kumahashi, K., Kohda, Y., Ido, K., Shioya, A., Misaki, K., & Kasuga, K. (2021) · Acta Neurochirurgica · doi:10.1007/s00701-021-04751-0 · Cited by 18
Amyotrophic lateral sclerosis and organ donation: Is there risk of disease transmission?
Holmes, B. B., & Diamond, M. I. (2012) · Annals of Neurology · doi:10.1002/ana.23684 · Cited by 18
The release and transmission of amyloid precursor protein via exosomes
Zheng, T., Wu, X., Wei, X., Wang, M., & Zhang, B. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.12.009 · Cited by 18
Emerging links between cell competition and Alzheimer's disease
Coelho, D. S., & Moreno, E. (2019) · Journal of Cell Science · doi:10.1242/jcs.231258 · Cited by 19
Brain virtual histology with X-ray phase-contrast tomography Part II: 3D morphologies of amyloid-β plaques in Alzheimer’s disease models
Chourrout, M., Roux, M., Boisvert, C., Gislard, C., Legland, D., Arganda‐Carreras, I., Olivier, C., Peyrin, F., Boutin, H., Rama, N., et al. (2021) · Biomedical Optics Express · doi:10.1364/boe.438890 · Cited by 17
Calcium channel blockade attenuates abnormal synaptic transmission in the dentate gyrus elicited by entorhinal amyloidopathy
Pourbadie, H. G., Naderi, N., Janahmadi, M., Mehranfard, N., & Motamedi, F. (2016) · Synapse · doi:10.1002/syn.21915 · Cited by 16
Preventing the Spread of Alzheimer’s Disease Neuropathology: A Role for Calcilytics?
Chiarini, A., Gardenal, E., Whitfield, J., Chakravarthy, B., Armato, U., & Prà, I. D. (2015) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201016666150505123813 · Cited by 14
Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUS
Vazquez‐Sanchez, S., Tilkin, B., Gasset-Rosa, F., Zhang, S., Piol, D., McAlonis‐Downes, M., Artates, J. W., Govea-Perez, N., Verresen, Y., Guo, L. E., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00737-5 · Cited by 17
Trans‐seeding of Alzheimer‐related tau protein by a yeast prion
Flach, M., Leu, C., Martinisi, A., Skachokova, Z. K., Frank, S., Tolnay, M., Stahlberg, H., & Winkler, D. T. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12581 · Cited by 13
Context dependence of protein misfolding and structural strains in neurodegenerative diseases
Mehta, A. K., Rosen, R. F., Childers, W. S., Gehman, J. D., Walker, L. C., & Lynn, D. G. (2013) · Biopolymers · doi:10.1002/bip.22283 · Cited by 14
Self-citation
Конвергенция концепций патогенеза болезни Альцгеймера
Kozin, S. A., & Makarov, A. А. (2019) · Molecular Biology · doi:10.1134/s0026898419060107 · Cited by 14
The Role of Amyloid PET in Diagnosing Possible Transmissible Cerebral Amyloid Angiopathy in Young Adults with a History of Neurosurgery: A Case Series
Michiels, L., Weehaeghe, D. V., Vandenberghe, R. R., Demeestere, J., Laere, K. V., & Lemmens, R. (2021) · Cerebrovascular Diseases · doi:10.1159/000514139 · Cited by 14
Biology and Genetics of PrP Prion StrainsPreprint
Ghaemmaghami, S. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026922 · Cited by 14
Netrin-1 signaling pathway mechanisms in neurodegenerative diseases
Zhu, K., Wang, H., Ye, K., Chen, G., & Zhang, Z. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01573 · Cited by 13
Association of Transfusion With Risks of Dementia or Alzheimer’s Disease: A Population-Based Cohort Study
Lin, S.-Y., Hsu, W., Lin, C., Lin, C., Yeh, H., & Kao, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00571 · Cited by 13
Developing Trojan horses to induce, diagnose and suppress Alzheimer’s pathology
Aziz, A. A., & Amtul, Z. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104471 · Cited by 12
Animal models for prion-like diseases
Fernández‐Borges, N., Eraña, H., Venegas, V., Elezgarai, S. R., Harrathi, C., & Castilla, J. (2015) · Virus Research · doi:10.1016/j.virusres.2015.04.014 · Cited by 13
Key roles of Tyr 10 in Cu bound Aβ complexes and its relevance to Alzheimer's disease
Lu, N., Li, J., & Gao, Z. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.07.009 · Cited by 12
The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration
Öztürk, M. M., Emgård, J., García‐Revilla, J., Fernández‐Calle, R., Yang, Y., Deierborg, T., & Roos, T. T. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf087 · Cited by 14
Neuronal ABCA7 deficiency aggravates mitochondrial dysfunction and neurodegeneration in Alzheimer's disease
Wang, N., Pan, Y., Starling, S. C., Haskell, D. H., Quintero, A. C., Kawatani, K., Inoue, Y., Shue, F., Ma, X., Aikawa, T., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70112 · Cited by 11
Decontamination of prions
McDonnell, G. E. (2014) · Elsevier eBooks · doi:10.1533/9780857096692.2.346 · Cited by 11
Strain Specificity and Drug Resistance in Anti-Prion Therapy
Miller-Vedam, L. E., & Ghaemmaghami, S. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660168 · Cited by 11
Recurrent Intracerebral Haematomas Due to Amyloid Angyopathy after Lyodura Transplantation in Childhood
Fabjan, M., Jurečič, A., Jerala, M., Oblak, J. P., & Frol, S. (2024) · Neurology International · doi:10.3390/neurolint16020023 · Cited by 10

Authors: Eisele, Y. S., Bolmont, T., Heikenwalder, M., Langer, F., Jacobson, L. H., Yan, Z.-X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C., & Jucker, M.
Affiliations: Hertie Institute for Clinical Brain Research (DE)
Department of Pathology, Institute for Neuropathology, University Hospital, Zürich, CH-8091 Switzerland;
Novartis (Switzerland) (CH)
SMP GmbH, D-72072 Tübingen, Germany;
University Hospital Zurich (CH)
Emory University (US)
German Center for Neurodegenerative Diseases (DE)
ORCID: Eisele, Yvonne S.
Bolmont, Tristan
Langer, Franziska
Jacobson, Laura H.
Aguzzi, Adriano
Walker, Lary C.
Jucker, Mathias
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2009-08-04
Volume: 106
Issue: 31
Pages: 12926-12931
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0903200106
PMC: PMC2722323
OpenAlex: W1928837524
Cited by: 279
References: 44
Citations by year: 2026: 4 · 2025: 7 · 2024: 14 · 2023: 6 · 2022: 10 · 2021: 15 · 2020: 22 · 2019: 17 · 2018: 18 · 2017: 18 · 2016: 21 · 2015: 21 · 2014: 20 · 2013: 28 · 2012: 17
FWCI: 12.81
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Funders: National Center for Research Resources (RR-00 165, P51RR000165)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: beta-amyloidosis, Alzheimer's disease, amyloid-beta aggregation, APP23 transgenic mice, intracerebral injection, prion-like transmission, plasma sterilization, brain region specificity, amyloid deposition
MeSH terms: Amyloidosis, Animals, Brain Diseases, Female, Male, Mice, Inbred C57BL, Mice, Transgenic, Amyloid beta-Peptides, Prion Diseases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks